Business Context and Reporting Period
DaVita HealthCare Partners Inc. filed this Form 8-K on July 31, 2014, to disclose financial results for the three months ended June 30, 2014. The company operates primarily in Kidney Care and Home Care Partners (HCP) divisions.
Key Financial Metrics
| Metric | Value (in millions) |
|---|---|
| Net Income (DaVita) | $148 |
| Net Income (Noncontrolling Interests) | $34 |
| Income Tax Expense | $101 |
| Debt Expense | $106 |
| Debt Refinancing Charges | $97 |
| Consolidated Operating Income | $484 |
| Kidney Care Operating Income | $402 |
| HCP Operating Income | $82 |
| HCP Adjusted EBITDA | $125 |
The filing does not provide specific data on total revenue, cash flows from operations, total debt balances, or liquidity ratios.
Material Changes and Adjustments
The filing highlights a significant non-GAAP adjustment for the HCP division. While reported operating income for HCP was $82 million, normalized operating income was $55 million. This $27 million adjustment primarily relates to net deferred revenues associated with maintaining existing physician networks in new markets. Additionally, the company incurred $97 million in debt refinancing charges during the period.
Management Commentary and Non-GAAP Measures
Management utilizes Adjusted EBITDA and adjusted operating income to assess performance in HCP's legacy and new markets. Adjusted EBITDA is defined as net income before income taxes, net debt expense, depreciation, amortization, and long-term incentive compensation. The company explicitly states these measures are not GAAP-compliant, may not be comparable to other companies, and are not predictive of future results. The filing contains no forward-looking guidance or specific risk disclosures beyond standard non-GAAP disclaimers.
Investor Verification Checklist
- Verify the impact of the $97 million debt refinancing charge on future interest obligations.
- Confirm the sustainability of the $27 million deferred revenue adjustment in HCP's new markets.
- Review the full 10-Q for total revenue figures and cash flow statements, which are absent in this 8-K.
- Assess the breakdown of debt expense ($106 million) relative to the company's total debt load.